
A recent study established a clinically useful nomogram to complement the assessment of left ventricular hypertrophy (LVH) in hypertensive patients without ECG-LVH based on Cornell product criteria. A cross-sectional dataset was divided into development and verification sets and identified eleven risk factors including hypertension awareness, age, and sex. The developed nomogram demonstrated good predictive ability, with areas under the curve of 0.724 and 0.700 for development and validation datasets, respectively and provided valuable insights into Echo-LVH risk assessment.
Like
Save
Share